Search Results for: Pulmonary

5304 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
BAD and SFN BCL2 associated agonist of cell death stratifin
  • Activation of BAD and translocation to mitochondria
  • Activation of BAD and translocation to mitochondria
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • NRAGE signals death through JNK
  • AKT phosphorylates targets in the cytosol
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • Regulation of localization of FOXO transcription factors
  • Navitoclax
BAG1 and MAPT BAG cochaperone 1 microtubule associated protein tau
  • Regulation of HSF1-mediated heat shock response
  • Caspase-mediated cleavage of cytoskeletal proteins
  • (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
  • Lansoprazole
  • Astemizole
  • Paclitaxel
  • Docetaxel
  • Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease
  • Frontotemporal lobar degeneration (FTLD), including: Pick disease of brain; Frontotemporal dementia (FTD); Ubiquitin-positive frontotemporal dementia (UP-FTD); Progressive supranuclear palsy type 1 (PSNP1); Inclusion body myopathy with early-onset paget disease and frontotemporal dementia (IBMPFD); Frontotemporal dementia, chromosome 3-linked (FTD3)
  • Progressive supranuclear palsy (PSP); Steele-Richardson-Olszewski syndrome
BAG1 and HSPA4 BAG cochaperone 1 heat shock protein family A (Hsp70) member 4
  • Regulation of HSF1-mediated heat shock response
  • Regulation of HSF1-mediated heat shock response
  • (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
  • Phenethyl Isothiocyanate
ADGRB1 and ELMO1 adhesion G protein-coupled receptor B1 engulfment and cell motility 1
  • Nef and signal transduction
  • Regulation of actin dynamics for phagocytic cup formation
  • VEGFA-VEGFR2 Pathway
  • PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
  • FCGR3A-mediated phagocytosis
ADGRB1 and PDZD2 adhesion G protein-coupled receptor B1 PDZ domain containing 2
ADGRB3 and ELMO1 adhesion G protein-coupled receptor B3 engulfment and cell motility 1
  • Nef and signal transduction
  • Regulation of actin dynamics for phagocytic cup formation
  • VEGFA-VEGFR2 Pathway
  • PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
  • FCGR3A-mediated phagocytosis
BAK1 and HSPD1 BCL2 antagonist/killer 1 heat shock protein family D (Hsp60) member 1
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • Mitochondrial protein import
  • Mitochondrial protein import
  • TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
  • Copper
  • Hereditary spastic paraplegia (SPG)
  • Hypomyelinating leukodystrophy (HLD); Pelizaeus-Merzbacher disease (PMD)
BAK1 and BCL2L10 BCL2 antagonist/killer 1 BCL2 like 10
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
BAK1 and NFKBIB BCL2 antagonist/killer 1 NFKB inhibitor beta
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • Activation of NF-kappaB in B cells
  • RIP-mediated NFkB activation via ZBP1
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • TRAF6 mediated NF-kB activation
BAK1 and MFN1 BCL2 antagonist/killer 1 mitofusin 1
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • Pink/Parkin Mediated Mitophagy
  • Factors involved in megakaryocyte development and platelet production
BAK1 and BAX BCL2 antagonist/killer 1 BCL2 associated X, apoptosis regulator
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • Release of apoptotic factors from the mitochondria
  • Activation, translocation and oligomerization of BAX
  • TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Transcriptional regulation by RUNX2
  • NTRK3 as a dependence receptor
  • Colorectal cancer
BAK1 and ERN1 BCL2 antagonist/killer 1 endoplasmic reticulum to nucleus signaling 1
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • IRE1alpha activates chaperones
  • IRE1alpha activates chaperones
  • N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine
BAK1 and MCL1 BCL2 antagonist/killer 1 MCL1 apoptosis regulator, BCL2 family member
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • Interleukin-4 and Interleukin-13 signaling
BAK1 and BCL2 BCL2 antagonist/killer 1 BCL2 apoptosis regulator
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • Activation of BAD and translocation to mitochondria
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Interleukin-4 and Interleukin-13 signaling
  • The NLRP1 inflammasome
  • Estrogen-dependent gene expression
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Ibuprofen
  • Paclitaxel
  • Docetaxel
  • Rasagiline
  • S-8184
  • Paclitaxel docosahexaenoic acid
  • Glycine betaine
  • Eribulin
  • Dexibuprofen
  • Venetoclax
  • Obatoclax
  • Navitoclax
  • Choriocarcinoma
  • Gastric cancer
  • Chronic lymphocytic leukemia (CLL)
  • Small cell lung cancer
  • Kaposi's sarcoma
  • Nasopharyngeal cancer
  • Cervical cancer
BAK1 and BCL2A1 BCL2 antagonist/killer 1 BCL2 related protein A1
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
BAK1 and BCL2L1 BCL2 antagonist/killer 1 BCL2 like 1
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Interleukin-4 and Interleukin-13 signaling
  • The NLRP1 inflammasome
  • 4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID
  • Gossypol
BAK1 and DBN1 BCL2 antagonist/killer 1 drebrin 1
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
BAK1 and HSD17B4 BCL2 antagonist/killer 1 hydroxysteroid 17-beta dehydrogenase 4
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • alpha-linolenic acid (ALA) metabolism
  • Beta-oxidation of pristanoyl-CoA
  • Beta-oxidation of very long chain fatty acids
  • Peroxisomal protein import
  • Peroxisomal protein import
  • TYSND1 cleaves peroxisomal proteins
  • NADH
  • 3r-Hydroxydecanoyl-Coa
  • Peroxisomal beta-oxidation enzyme deficiency, including: Acyl-CoA oxidase (ACOX) deficiency; D-bifunctional protein (DBP) deficiency; Perrault syndrome; Sterol carrier protein X (SCPx) deficiency; 2-Methylacyl-CoA racemase (AMCR) deficiency; Hypercholanemia
BAK1 and TP53 BCL2 antagonist/killer 1 tumor protein p53
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • Activation of NOXA and translocation to mitochondria
  • Activation of PUMA and translocation to mitochondria
  • Pre-NOTCH Transcription and Translation
  • Oxidative Stress Induced Senescence
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Oncogene Induced Senescence
  • DNA Damage/Telomere Stress Induced Senescence
  • SUMOylation of transcription factors
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Association of TriC/CCT with target proteins during biosynthesis
  • TP53 Regulates Metabolic Genes
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 Regulates Transcription of DNA Repair Genes
  • TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
  • TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
  • TP53 Regulates Transcription of Caspase Activators and Caspases
  • TP53 Regulates Transcription of Death Receptors and Ligands
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • Regulation of TP53 Expression
  • Regulation of TP53 Activity through Phosphorylation
  • Regulation of TP53 Degradation
  • Regulation of TP53 Activity through Acetylation
  • Regulation of TP53 Activity through Association with Co-factors
  • Regulation of TP53 Activity through Methylation
  • PI5P Regulates TP53 Acetylation
  • G2/M DNA damage checkpoint
  • G2/M Checkpoints
  • Stabilization of p53
  • Transcriptional activation of cell cycle inhibitor p21
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • Transcriptional Regulation by VENTX
  • RUNX3 regulates CDKN1A transcription
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Factors involved in megakaryocyte development and platelet production
  • Acetylsalicylic acid
  • Zinc
  • Triethyl Phosphate
  • AZD 3355
  • 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine
  • Osteosarcoma
  • Adrenal carcinoma
  • Thyroid cancer
  • Breast cancer
  • Basal cell carcinoma
  • Malignant melanoma
  • Pancreatic cancer
  • Gastric cancer
  • Malignant pleural mesothelioma
  • Non-small cell lung cancer
  • Esophageal cancer
  • Oral cancer
  • Multiple myeloma
  • Small cell lung cancer
  • Li-Fraumeni syndrome, including: Classic Li-Fraumeni syndrome (LFS); LFS-like syndrome (LFSL)
  • Glioma
  • Squamous cell carcinoma
  • Kaposi's sarcoma
  • Cholangiocarcinoma
  • Gallbladder cancer
  • Cancer of the anal canal
  • Hepatocellular carcinoma
  • Choriocarcinoma
  • Vulvar cancer
  • Choroid plexus papilloma
  • Burkitt lymphoma
  • Adult T-cell leukemia
  • Hairy-cell leukemia
  • Bladder cancer
  • Chronic lymphocytic leukemia (CLL)
  • Penile cancer
  • Endometrial Cancer
  • Ovarian cancer
  • Colorectal cancer
  • Laryngeal cancer
  • Chronic myeloid leukemia (CML)
BAK1 and VDAC1 BCL2 antagonist/killer 1 voltage dependent anion channel 1
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
  • Mitochondrial protein import
  • Pink/Parkin Mediated Mitophagy
  • Ub-specific processing proteases
  • Pyruvate metabolism
  • Mitochondrial calcium ion transport
  • Aluminium monostearate

Page 34 out of 266 pages